Know Cancer

or
forgot password

B-CLL Subgroups: Maturation Stage and Gene Expression


N/A
18 Years
N/A
Open (Enrolling)
Both
Chronic Lymphocytic Leukemia

Thank you

Trial Information

B-CLL Subgroups: Maturation Stage and Gene Expression


Inclusion Criteria:



- 18 years of age,

- Patients must be able to contribute the required amount of blood without compromising
their well being,

- Participants must be willing to be contacted again in the future for additional blood
drawing.

Exclusion Criteria:

- Patients who are known to be anemic, with a hemoglobin < 8,

- Patients who are known to be infected with HIV.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Outcome Measure:

differentiating B-CLL cells by the presence or absence of mutations in antibody genes and/or by the percentage of cells expressing CD38 and the differnce in clinical disease course and outcome for each group

Outcome Time Frame:

follow through the clinical disease course for each group

Safety Issue:

No

Principal Investigator

Nicholas Chiorazzi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

North Shore-LIJ Health System

Authority:

United States: Institutional Review Board

Study ID:

04-057

NCT ID:

NCT01030913

Start Date:

December 1999

Completion Date:

January 2015

Related Keywords:

  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Lymphoid

Name

Location

Feinstein Institute for Medical ResearchManhassett, New York  11030